Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: A double-blind placebo-controlled study

Phytomedicine

Volumn 14, Issue 2-3, 2007, Pages 87-95

  Omer, B ^a   Krebs, S ^b   Omer, H ^c   Noor, T O ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anti depressant effect; Artemisia absinthium; Crohn's disease; Regional colitis; Seda Crohn; Steroid sparing effect; Wormwood

Indexed keywords

AMINOSALICYLIC ACID; ARTEMISIA ABSINTHIUM EXTRACT; METHOTREXATE; SEDACROHN; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTEMISIA ABSINTHIUM; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFECT; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADULT; AGED; ARTEMISIA ABSINTHIUM; CROHN DISEASE; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PHYTOTHERAPY; PLANT PREPARATIONS; PREDNISONE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ARTEMISIA; ARTEMISIA ABSINTHIUM;

EID: 33846352895     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.01.001     Document Type: Article

References (13)

1. Berk T., Gordon S.J., Choi H.Y., and Cooper H.S. Cytomegalovirus infection of the colon: a possible role in exacerbation of inflammatory bowel disease. Am. J. Gastroenterol. 80 (1985) 355-360
2. Best W.R., Becktel J.M., Singleton J.W., and Kern Jr. F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70 (1976) 439-444
3. Chaisson H., Belanger A., Bostanian N., Vincent C., and Poliquin A. Acaricidal properties of Artemisia absinthium and Tanacetum vulgare (Asteraceae) essential oils obtained by three methods of extraction. J. Econ. Entomol. 94 (2000) 171-176
4. Encyclopaedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics, 1996. second ed. Wiley, New York, pp. 1-3.
5. Feagan B., Rochon J., and Fedorak R. Methotrexate for the treatment of Crohn's disease. N. Engl. J. Med. 332 (1995) 292-297
6. Gregor G.C., McDonald J.W.D., Klar N., and Feagan B.G. An evaluation of utility measurement in Crohn's disease. Inflamm. Bowel Dis. 3 (1997) 265-276
7. Hanauer S.B., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., Rachmilewtz D., Wolf D.C., Olson A., Bao W., Rutgeerts P., and ACCENT Study Group. Maintenance inflixmab for Crohn's disease: the ACCENT I randomised trial. Lancet 359 (2002) 1541-1549
8. Karim, R., Omer, L.M.O., 1996. Plant based treatment of depression. In: Tenth International Congress of Virology, Jerusalem, Israel.
9. List, P.H., Hörhammer, L., 1973. In: Hager's Handbuch der Pharmazeutischen Praxis für Apotheker, Arzneimittelhersteller, Ärzte und Medizinalbeamte, vol. 3. Springer, Berlin, Heidelberg, New York, pp. 254-259.
10. Sandborn W., Sutherland L., and Pearson D. Azathiprine or 6-marceptopurine for inducing remission of Crohn's disease. Cochrane Database Syst. Rev. 2 (2000) CD000545
11. Wakefield A.J., Fox J.D., Sawyerr A.M., Taylor J.E., Sweenie C.H., Smith M., Emery V.C., Hudson M., Tedder R.S., and Pounder R.E. Detection of herpes DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J. Med. Virol. 38 (1992) 183-190
12. In: Weis R.F. (Ed). Herbal Medicine (1988), Ab Arcanum, Gothenberg, Sweden 79-81
13. Yanai H., Shimozu N., Nagasaki S., Mitani N., and Okita K. Epstein-Barr virus infection of the colon with inflammatory bowel disease. Am. J. Gastroenterol. 94 (1999) 1582-1586